Jiang, Wei-Xi
Li, Zhi-Peng
Zhao, Qi
Gao, Meng-Qiu
Long, Qian
Wang, Wei-Bing
Huang, Fei
Wang, Ni
Tang, Sheng-Lan https://orcid.org/0000-0001-9214-7787
Funding for this research was provided by:
the Bill and Melinda Gates Foundation (OPP1149395)
Article History
Received: 9 December 2020
Accepted: 23 March 2021
First Online: 21 April 2021
Declarations
:
: The implementation of China NHC-Gates TB Phase III project has received the ethical approval from China CDC (No. 201626). The protocol of the overall study design and data collection tools was reviewed and approved by the Institutional Review Board of Duke University (IRB Approval code: 2017-0768). Consent form was obtained before individual data collection and could be provided upon request.
: Consent form was obtained before individual data collection and could be provided upon request.
: All authors declare no competing interests.